VVZ API is not affiliated with ETH Zurich. Data might be outdated or incorrect. Please view the official ETHZ Vorlesungsverzeichnis for binding information.
Therapeutische Proteine
Last Updated: 2026-02-05 14:54:59
Abstract
Get students familiar with advanced Immunological concepts of Pharmaceutical RelevanceDiscuss features of the main recombinant biopharmaceuticals approved in Europe and in the U.S.
Content
0. Chapters 11-14 of the Janaway et al. "Immunobiology V" book (Garland) 1. A brief history of biotech industry 2. Recombinant cytokines and growth hormones 3. Recombinant blood coagulation and growth hormones 4. Recominant vaccines 5. Recombinant antibodies 6. Miscallaneaous 7. IPR considerations 8. Future perspectives
Resources
Literature
Immunobiology: The Immune System in Health & Disease Fifth Edition Charles A. Janeway, Paul Travers, Mark Walport, Mark Shlomchik © 2001 Paperback 732 pages 500 full-color figures - includes CD-ROM with 27 animations ISBN 0?8153?3642?X [ www.garlandscience.com ] AND Gary Walsh (2003) "Biopharmaceutical benchmark - 2003", Nature Biotechnology, vol. 21, pages 865-870. (including tables)
General Information
- Language
- German
- Frequency
- Yearly recurring
Examination
- Type
- session examination
- Mode
- oral 30 minutes
Course Components
| Type | Title | Time & Place | Hours |
|---|---|---|---|
| lecture with exercise | Therapeutische Proteine |
|
1 h weekly |